Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/05/2012WO2012091041A1 Insulin secretion promoter
07/05/2012WO2012090207A2 Par1 and par2 c-tail peptides and peptide mimetics
07/05/2012WO2012090006A2 Methods for improving fracture healing and bone formation
07/05/2012WO2012089783A1 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
07/05/2012WO2012089782A1 Fiber and probiotics for reducing intestinal symptoms related to stress
07/05/2012WO2012089736A1 Sirna against cbl-b and optionally il2 und il12 for use in the treatment of cancer
07/05/2012WO2012089570A1 Peptide molecules for treating mitochondrial pathologies
07/05/2012WO2012088608A1 Compositions comprising natriuretic peptides and methods of use thereof
07/05/2012WO2012088563A1 Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof
07/05/2012WO2012062228A3 Polypeptides derived from il-2 having agonist activity, for the therapy of cancer and chronic infections
07/05/2012WO2012053827A9 Composition containing peptide ligand bonding with cxcr2 for treating infective and inflammatory diseases
07/05/2012WO2012050921A3 Nd2 peptides and methods of treating neurological disease
07/05/2012WO2012048125A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
07/05/2012WO2012045083A9 Minimizing intestinal dysfunction
07/05/2012WO2012037498A3 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
07/05/2012WO2012026988A3 Dendrimeric peptides, pharmaceutical compositions and methods of using the same
07/05/2012WO2012019184A3 Compositions and methods for detecting, diagnosing, and treating cancer
07/05/2012WO2012006598A3 Stabilized insulinotropic peptides and methods of use
07/05/2012WO2012006384A3 Rothia species gluten-degrading enzymes and uses thereof
07/05/2012WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
07/05/2012WO2009114757A3 A novel pharmaceutical preparation for preeclampsia, eclampsia, and toxemia and their related symptoms and related disorders of pregnancy
07/05/2012US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof
07/05/2012US20120172525 Compositions containing inclusion complexes
07/05/2012US20120172422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid
07/05/2012US20120172319 Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
07/05/2012US20120172318 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR
07/05/2012US20120172317 Silk fibroin hydrogels and uses thereof
07/05/2012US20120172316 Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7s globulin alfa' subunit involved in hep g2 cell cholesterol homeostasis
07/05/2012US20120172315 Peptides Used for Treating Cancers and, in Particular, Chronic Lymphoid Leukaemia
07/05/2012US20120172314 Klotho Protein and Related Compounds for the Treatment and Diagnosis of Cancer
07/05/2012US20120172313 Treatment of proliferative diseases
07/05/2012US20120172312 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
07/05/2012US20120172311 Peptidomimetic macrocycles
07/05/2012US20120172310 Soluble Guanylyl Cyclase a1 and a-8r Peptide as Diagnostic Markers of and Therapeutic Targets for Prostate Cancer
07/05/2012US20120172309 Transglutaminase-activating peptide and cosmetic or pharmaceutial composition containing same
07/05/2012US20120172308 Oligopeptides And Their Use In Cosmetics
07/05/2012US20120172307 Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
07/05/2012US20120172306 Use of HASF as a Protective Agent Against Ischemic Tissue Damage
07/05/2012US20120172305 Retro-inverso peptides derived from interleukin-6
07/05/2012US20120172304 Intranasal carbetocin formulations and methods for the treatment of autism
07/05/2012US20120172303 Growth Hormones with Prolonged In-Vivo Efficacy
07/05/2012US20120172302 Composition for the treatment of benign prostate hyperplasia
07/05/2012US20120172301 Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ace2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling
07/05/2012US20120172300 Remodeling and glycopegylation of fibroblast growth factor (fgf)
07/05/2012US20120172299 Purification of erythropoietin
07/05/2012US20120172298 Glp-1 and fgf21 combinations for treatment of diabetes type 2
07/05/2012US20120172297 Synthetic human genes and polypeptides and their use in the treatment of autoimmune diseases
07/05/2012US20120172296 Water-soluble aie luminogen for monitoring and retardation of amyloid fibrillation of insulin
07/05/2012US20120172295 Gip receptor-active glucagon compounds
07/05/2012US20120172294 Treatment of diseases
07/05/2012US20120172293 Peptide and use thereof
07/05/2012US20120172292 Method for protection of antimicrobial and anticancer drugs from inactivation by nitric oxide
07/05/2012US20120172291 Macrocyclic hepatitis c serine protease inhibitors
07/05/2012US20120172290 Anti-Viral Compounds
07/05/2012US20120172289 Multifunctional glycopeptide antibiotic derivatives for fluorescent imaging and photoactive antimicrobial therapy
07/05/2012US20120172288 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012US20120172287 Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide
07/05/2012US20120172286 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120172284 Isozyme-specific antagonists of protein kinase c
07/05/2012US20120172283 Methods and compositions for targeted drug delivery
07/05/2012US20120171779 Antibodies that specifically bind hedgehog-derived polypeptides
07/05/2012US20120171765 Factor VII or VIIa - Like Molecules
07/05/2012US20120171305 Response Prediction in Cancer Treatment Involving p53 Adapted Cancer Therapy
07/05/2012US20120171303 Compositions and methods for ehnancing cognitive and related functions in animals
07/05/2012US20120171291 Peptide-carrying nanoparticles
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171259 Orally absorbed pharmaceutical formulation and method of administration
07/05/2012US20120171257 Cell-guiding fibroinductive and angiogenic scaffolds for periodontal tissue engineering
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171253 Fibromodulin Peptide
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171247 Novel proteins within the type e botulinum neurotoxin complex
07/05/2012US20120171236 Immunization against chlamydia pneumoniae
07/05/2012US20120171234 Novel Biologically Active Peptides and their New Uses
07/05/2012US20120171227 Pro-drug complexes and related methods of use
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171220 Further use of protein kinase n beta
07/05/2012US20120171214 Polypeptides
07/05/2012US20120171210 Methods and compositions for inhibiting c-met dimerization and activation
07/05/2012US20120171208 Anti-PRO87299 Antibodies
07/05/2012US20120171206 Methods of stimulating liver regeneration
07/05/2012US20120171194 Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
07/05/2012US20120171192 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
07/05/2012US20120171191 Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
07/05/2012US20120171190 Methods for diagnosing chronic diarrhea through protein secretion analysis
07/05/2012US20120171187 Debriding composition from bromelain and methods of production thereof
07/05/2012US20120171186 method for producing a nutraceutical composition and the nutraceutical produced by the method
07/05/2012US20120171184 Cellular hydration compositions
07/05/2012US20120171176 Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract
07/05/2012US20120171170 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
07/05/2012US20120171164 Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections
07/05/2012US20120171163 Method for inhibiting a bacterial invasive mechanism using a nutritional composition
07/05/2012US20120171158 METHODS OF USING sIP-10, CD26 INHIBITORS AND CXCR3 LEVELS IN A SAMPLE TO ASSESS CLEARANCE OF INFECTION, RESPONSE TO INTERFERON THERAPY, AND TREATING CHRONIC INFECTIONS
07/05/2012US20120171157 Macrocyclic Inhibitors Of Hepatitis C Virus
07/05/2012US20120171156 Methods and compounds for reducing allergic reactions to hair dyes
07/05/2012US20120171153 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
07/05/2012US20120171122 Loop-Variant Pdz Domains As Biotherapeutics, Diagnostics And Research Reagents
07/05/2012CA2823297A1 Non-natural mic proteins
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 3163